Back to Journals » International Journal of General Medicine » Volume 6
Chronic rhinosinusitis and emerging treatment options
Authors Piromchai P, Kasemsiri P, Laohasiriwong S, Thanaviratananich S
Received 28 September 2012
Accepted for publication 8 May 2013
Published 7 June 2013 Volume 2013:6 Pages 453—464
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Patorn Piromchai,1,2 Pornthep Kasemsiri,1,3 Supawan Laohasiriwong,1 Sanguansak Thanaviratananich1
1Department of Otorhinolaryngology, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand; 2Department of Otolaryngology, Royal Victorian Eye and Ear Hospital/University of Melbourne, East Melbourne, Australia; 3Department of Otolaryngology – Head and Neck Surgery, Wexner Medical Center at the Ohio State University Medical Center, Columbus, Ohio, USA
Abstract: This review describes the epidemiology and various treatments in chronic rhinosinusitis (CRS) with nasal polyps (CRSwNP) and CRS without nasal polyps (CRSsNP). Evidence for short-term use of systemic corticosteroids has been shown to be favorable in CRSwNP, but still limited in CRSsNP. Topical corticosteroids improve symptom scores in both CRS subgroups. The role of microbes in CRS is still controversial. Culture-directed antibiotics are recommended for CRSsNP with exacerbation. Long-term use of low dosage antibiotics is recommended for CRSsNP for their anti-inflammatory effects. Other emerging treatment options are also discussed.
Keywords: rhinosinusitis, chronic, nasal polyps, therapy, sinus
© 2013 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.